Delivery Order SPE2DB22D3301-SPE2DB26FX3PY
Award Date 10/21/25
Potential Completion Date 11/12/25
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $14,221.60 on June 30, 2025, for the supply of Enhertu 100 mg vials with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a pediatric-focused pharmaceutical procurement supporting federal medical supply requirements. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a Delivery Order (4569006087) valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with a completion date of August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The company serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials. The contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, utilizes firm fixed-price pricing and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Enhertu 100 mg vials with a ceiling value of $10,666.14 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Enhertu 100 mg vials, valued at $17,777.00, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Enhertu 100 mg vials, a specialized oncology pharmaceutical. This competitively awarded, non-set-aside contract has a ceiling value of $17.8K and a firm fixed price structure, with performance scheduled for completion by October 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,110.80 by the Defense Logistics Agency for 100 milligram vials of Enhertu, a prescription oncology medication. The contract, awarded on August 26, 2025, with completion targeted for September 17, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a $17.8K delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Enhertu 100 mg vials, with completion targeted for October 14, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Enhertu 100 mg vials valued at $10,666.20 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award involved no set-aside designation, indicating competitive...
- The Defense Logistics Agency's Medical Supply Chain awarded a $53,331 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent. The contract was competitively awarded without set-aside provisions and is scheduled for completion by September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order is a child...